West Pharmaceutical Services, Inc. (WST) Tops Q4 EPS by 4c, Offers FY12 EPS Outlook
Tweet
Share
E-mailGet Alerts WST Hot Sheet
Price: $390.20 +4.01%
EPS Growth %: -34.3%
Financial Fact:
Income before income taxes: 49.3M
Today's EPS Names:
SFST, VLTO, CLIR, More
EPS Growth %: -34.3%
Financial Fact:
Income before income taxes: 49.3M
Today's EPS Names:
SFST, VLTO, CLIR, More
Join SI Premium – FREE
West Pharmaceutical Services, Inc. (NYSE: WST) reported Q4 EPS of $0.59, $0.04 better than the analyst estimate of $0.55. Revenue for the quarter came in at $295.4 million versus the consensus estimate of $290.05 million.
West Pharmaceutical Services, Inc. sees FY2012 EPS of $2.37-$2.55, versus the consensus of $2.51.
For earnings history and earnings-related data on West Pharmaceutical Services, Inc. (WST) click here.
West Pharmaceutical Services, Inc. sees FY2012 EPS of $2.37-$2.55, versus the consensus of $2.51.
For earnings history and earnings-related data on West Pharmaceutical Services, Inc. (WST) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tesla touts acceleration of new models, but Q1 results fall short of estimates
- Avangrid (AGR) Tops Q1 EPS by 19c
- Stride Inc. (LRN) Tops Q3 EPS by 17c, provides guidance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
